Table of Contents 1 Market Overview 1.1 Orphan Drugs Introduction 1.2 Market Analysis by Type 1.2.1 Oncology 1.2.2 Gastrointestinal 1.2.3 Pulmonary 1.2.4 Neurology 1.2.5 Hematology 1.2.6 Cardio-vascular 1.2.7 Metabolic disorders 1.2.8 Endocrinology 1.2.9 Infectious diseases 1.2.10 Others 1.3 Market Analysis by Applications 1.3.1 Hospital Pharmacies 1.3.2 Speciality Pharmacies 1.3.3 Retail pharmacies 1.3.4 Others 1.4 Market Analysis by Regions 1.4.1 North America (United States, Canada and Mexico) 1.4.1.1 United States Market States and Outlook (2013-2023) 1.4.1.2 Canada Market States and Outlook (2013-2023) 1.4.1.3 Mexico Market States and Outlook (2013-2023) 1.4.2 Europe (Germany, France, UK, Russia and Italy) 1.4.2.1 Germany Market States and Outlook (2013-2023) 1.4.2.2 France Market States and Outlook (2013-2023) 1.4.2.3 UK Market States and Outlook (2013-2023) 1.4.2.4 Russia Market States and Outlook (2013-2023) 1.4.2.5 Italy Market States and Outlook (2013-2023) 1.4.3 Asia-Pacific (China, Japan, Korea, India and Southeast Asia) 1.4.3.1 China Market States and Outlook (2013-2023) 1.4.3.2 Japan Market States and Outlook (2013-2023) 1.4.3.3 Korea Market States and Outlook (2013-2023) 1.4.3.4 India Market States and Outlook (2013-2023) 1.4.3.5 Southeast Asia Market States and Outlook (2013-2023) 1.4.4 South America, Middle East and Africa 1.4.4.1 Brazil Market States and Outlook (2013-2023) 1.4.4.2 Egypt Market States and Outlook (2013-2023) 1.4.4.3 Saudi Arabia Market States and Outlook (2013-2023) 1.4.4.4 South Africa Market States and Outlook (2013-2023) 1.4.4.5 Nigeria Market States and Outlook (2013-2023) 1.5 Market Dynamics 1.5.1 Market Opportunities 1.5.2 Market Risk 1.5.3 Market Driving Force 2 Manufacturers Profiles 2.1 Novartis 2.1.1 Business Overview 2.1.2 Orphan Drugs Type and Applications 2.1.2.1 Product A 2.1.2.2 Product B 2.1.3 Novartis Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.2 Bristol-Myers Squibb 2.2.1 Business Overview 2.2.2 Orphan Drugs Type and Applications 2.2.2.1 Product A 2.2.2.2 Product B 2.2.3 Bristol-Myers Squibb Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.3 Celgene 2.3.1 Business Overview 2.3.2 Orphan Drugs Type and Applications 2.3.2.1 Product A 2.3.2.2 Product B 2.3.3 Celgene Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.4 Roche 2.4.1 Business Overview 2.4.2 Orphan Drugs Type and Applications 2.4.2.1 Product A 2.4.2.2 Product B 2.4.3 Roche Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.5 Pfizer 2.5.1 Business Overview 2.5.2 Orphan Drugs Type and Applications 2.5.2.1 Product A 2.5.2.2 Product B 2.5.3 Pfizer Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.6 Sanofi 2.6.1 Business Overview 2.6.2 Orphan Drugs Type and Applications 2.6.2.1 Product A 2.6.2.2 Product B 2.6.3 Sanofi Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.7 Alexion Pharmaceuticals 2.7.1 Business Overview 2.7.2 Orphan Drugs Type and Applications 2.7.2.1 Product A 2.7.2.2 Product B 2.7.3 Alexion Pharmaceuticals Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.8 Eli Lilly 2.8.1 Business Overview 2.8.2 Orphan Drugs Type and Applications 2.8.2.1 Product A 2.8.2.2 Product B 2.8.3 Eli Lilly Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.9 Novo Nordisk 2.9.1 Business Overview 2.9.2 Orphan Drugs Type and Applications 2.9.2.1 Product A 2.9.2.2 Product B 2.9.3 Novo Nordisk Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.10 AstraZeneca 2.10.1 Business Overview 2.10.2 Orphan Drugs Type and Applications 2.10.2.1 Product A 2.10.2.2 Product B 2.10.3 AstraZeneca Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.11 Eisai 2.11.1 Business Overview 2.11.2 Orphan Drugs Type and Applications 2.11.2.1 Product A 2.11.2.2 Product B 2.11.3 Eisai Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.12 Daiichi Sankyo 2.12.1 Business Overview 2.12.2 Orphan Drugs Type and Applications 2.12.2.1 Product A 2.12.2.2 Product B 2.12.3 Daiichi Sankyo Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.13 Bayer 2.13.1 Business Overview 2.13.2 Orphan Drugs Type and Applications 2.13.2.1 Product A 2.13.2.2 Product B 2.13.3 Bayer Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.14 GlaxoSmithKline 2.14.1 Business Overview 2.14.2 Orphan Drugs Type and Applications 2.14.2.1 Product A 2.14.2.2 Product B 2.14.3 GlaxoSmithKline Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.15 Merck 2.15.1 Business Overview 2.15.2 Orphan Drugs Type and Applications 2.15.2.1 Product A 2.15.2.2 Product B 2.15.3 Merck Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.16 Johnson & Johnson 2.16.1 Business Overview 2.16.2 Orphan Drugs Type and Applications 2.16.2.1 Product A 2.16.2.2 Product B 2.16.3 Johnson & Johnson Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.17 Biogen 2.17.1 Business Overview 2.17.2 Orphan Drugs Type and Applications 2.17.2.1 Product A 2.17.2.2 Product B 2.17.3 Biogen Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.18 Shire 2.18.1 Business Overview 2.18.2 Orphan Drugs Type and Applications 2.18.2.1 Product A 2.18.2.2 Product B 2.18.3 Shire Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 2.19 Amgen 2.19.1 Business Overview 2.19.2 Orphan Drugs Type and Applications 2.19.2.1 Product A 2.19.2.2 Product B 2.19.3 Amgen Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) 3 Global Orphan Drugs Sales, Revenue, Market Share and Competition by Manufacturer (2016-2017) 3.1 Global Orphan Drugs Sales and Market Share by Manufacturer (2016-2017) 3.2 Global Orphan Drugs Revenue and Market Share by Manufacturer (2016-2017) 3.3 Market Concentration Rate 3.3.1 Top 3 Orphan Drugs Manufacturer Market Share in 2017 3.3.2 Top 6 Orphan Drugs Manufacturer Market Share in 2017 3.4 Market Competition Trend 4 Global Orphan Drugs Market Analysis by Regions 4.1 Global Orphan Drugs Sales, Revenue and Market Share by Regions 4.1.1 Global Orphan Drugs Sales and Market Share by Regions (2013-2018) 4.1.2 Global Orphan Drugs Revenue and Market Share by Regions (2013-2018) 4.2 North America Orphan Drugs Sales and Growth Rate (2013-2018) 4.3 Europe Orphan Drugs Sales and Growth Rate (2013-2018) 4.4 Asia-Pacific Orphan Drugs Sales and Growth Rate (2013-2018) 4.5 South America Orphan Drugs Sales and Growth Rate (2013-2018) 4.6 Middle East and Africa Orphan Drugs Sales and Growth Rate (2013-2018) 5 North America Orphan Drugs by Countries 5.1 North America Orphan Drugs Sales, Revenue and Market Share by Countries 5.1.1 North America Orphan Drugs Sales and Market Share by Countries (2013-2018) 5.1.2 North America Orphan Drugs Revenue and Market Share by Countries (2013-2018) 5.2 United States Orphan Drugs Sales and Growth Rate (2013-2018) 5.3 Canada Orphan Drugs Sales and Growth Rate (2013-2018) 5.4 Mexico Orphan Drugs Sales and Growth Rate (2013-2018) 6 Europe Orphan Drugs by Countries 6.1 Europe Orphan Drugs Sales, Revenue and Market Share by Countries 6.1.1 Europe Orphan Drugs Sales and Market Share by Countries (2013-2018) 6.1.2 Europe Orphan Drugs Revenue and Market Share by Countries (2013-2018) 6.2 Germany Orphan Drugs Sales and Growth Rate (2013-2018) 6.3 UK Orphan Drugs Sales and Growth Rate (2013-2018) 6.4 France Orphan Drugs Sales and Growth Rate (2013-2018) 6.5 Russia Orphan Drugs Sales and Growth Rate (2013-2018) 6.6 Italy Orphan Drugs Sales and Growth Rate (2013-2018) 7 Asia-Pacific Orphan Drugs by Countries 7.1 Asia-Pacific Orphan Drugs Sales, Revenue and Market Share by Countries 7.1.1 Asia-Pacific Orphan Drugs Sales and Market Share by Countries (2013-2018) 7.1.2 Asia-Pacific Orphan Drugs Revenue and Market Share by Countries (2013-2018) 7.2 China Orphan Drugs Sales and Growth Rate (2013-2018) 7.3 Japan Orphan Drugs Sales and Growth Rate (2013-2018) 7.4 Korea Orphan Drugs Sales and Growth Rate (2013-2018) 7.5 India Orphan Drugs Sales and Growth Rate (2013-2018) 7.6 Southeast Asia Orphan Drugs Sales and Growth Rate (2013-2018) 8 South America Orphan Drugs by Countries 8.1 South America Orphan Drugs Sales, Revenue and Market Share by Countries 8.1.1 South America Orphan Drugs Sales and Market Share by Countries (2013-2018) 8.1.2 South America Orphan Drugs Revenue and Market Share by Countries (2013-2018) 8.2 Brazil Orphan Drugs Sales and Growth Rate (2013-2018) 8.3 Argentina Orphan Drugs Sales and Growth Rate (2013-2018) 8.4 Colombia Orphan Drugs Sales and Growth Rate (2013-2018) 9 Middle East and Africa Orphan Drugs by Countries 9.1 Middle East and Africa Orphan Drugs Sales, Revenue and Market Share by Countries 9.1.1 Middle East and Africa Orphan Drugs Sales and Market Share by Countries (2013-2018) 9.1.2 Middle East and Africa Orphan Drugs Revenue and Market Share by Countries (2013-2018) 9.2 Saudi Arabia Orphan Drugs Sales and Growth Rate (2013-2018) 9.3 UAE Orphan Drugs Sales and Growth Rate (2013-2018) 9.4 Egypt Orphan Drugs Sales and Growth Rate (2013-2018) 9.5 Nigeria Orphan Drugs Sales and Growth Rate (2013-2018) 9.6 South Africa Orphan Drugs Sales and Growth Rate (2013-2018) 10 Global Orphan Drugs Market Segment by Type 10.1 Global Orphan Drugs Sales, Revenue and Market Share by Type (2013-2018) 10.1.1 Global Orphan Drugs Sales and Market Share by Type (2013-2018) 10.1.2 Global Orphan Drugs Revenue and Market Share by Type (2013-2018) 10.2 Oncology Sales Growth and Price 10.2.1 Global Oncology Sales Growth (2013-2018) 10.2.2 Global Oncology Price (2013-2018) 10.3 Gastrointestinal Sales Growth and Price 10.3.1 Global Gastrointestinal Sales Growth (2013-2018) 10.3.2 Global Gastrointestinal Price (2013-2018) 10.4 Pulmonary Sales Growth and Price 10.4.1 Global Pulmonary Sales Growth (2013-2018) 10.4.2 Global Pulmonary Price (2013-2018) 10.5 Neurology Sales Growth and Price 10.5.1 Global Neurology Sales Growth (2013-2018) 10.5.2 Global Neurology Price (2013-2018) 10.6 Hematology Sales Growth and Price 10.6.1 Global Hematology Sales Growth (2013-2018) 10.6.2 Global Hematology Price (2013-2018) 10.7 Cardio-vascular Sales Growth and Price 10.7.1 Global Cardio-vascular Sales Growth (2013-2018) 10.7.2 Global Cardio-vascular Price (2013-2018) 10.8 Metabolic disorders Sales Growth and Price 10.8.1 Global Metabolic disorders Sales Growth (2013-2018) 10.8.2 Global Metabolic disorders Price (2013-2018) 10.9 Endocrinology Sales Growth and Price 10.9.1 Global Endocrinology Sales Growth (2013-2018) 10.9.2 Global Endocrinology Price (2013-2018) 10.10 Infectious diseases Sales Growth and Price 10.10.1 Global Infectious diseases Sales Growth (2013-2018) 10.10.2 Global Infectious diseases Price (2013-2018) 10.11 Others Sales Growth and Price 10.11.1 Global Others Sales Growth (2013-2018) 10.11.2 Global Others Price (2013-2018) 11 Global Orphan Drugs Market Segment by Application 11.1 Global Orphan Drugs Sales Market Share by Application (2013-2018) 11.2 Hospital Pharmacies Sales Growth (2013-2018) 11.3 Speciality Pharmacies Sales Growth (2013-2018) 11.4 Retail pharmacies Sales Growth (2013-2018) 11.5 Others Sales Growth (2013-2018) 12 Orphan Drugs Market Forecast (2018-2023) 12.1 Global Orphan Drugs Sales, Revenue and Growth Rate (2018-2023) 12.2 Orphan Drugs Market Forecast by Regions (2018-2023) 12.2.1 North America Orphan Drugs Market Forecast (2018-2023) 12.2.2 Europe Orphan Drugs Market Forecast (2018-2023) 12.2.3 Asia-Pacific Orphan Drugs Market Forecast (2018-2023) 12.2.4 South America Orphan Drugs Market Forecast (2018-2023) 12.2.5 Middle East and Africa Orphan Drugs Market Forecast (2018-2023) 12.3 Orphan Drugs Market Forecast by Type (2018-2023) 12.3.1 Global Orphan Drugs Sales Forecast by Type (2018-2023) 12.3.2 Global Orphan Drugs Market Share Forecast by Type (2018-2023) 12.4 Orphan Drugs Market Forecast by Application (2018-2023) 12.4.1 Global Orphan Drugs Sales Forecast by Application (2018-2023) 12.4.2 Global Orphan Drugs Market Share Forecast by Application (2018-2023) 13 Sales Channel, Distributors, Traders and Dealers 13.1 Sales Channel 13.1.1 Direct Marketing 13.1.2 Indirect Marketing 13.1.3 Marketing Channel Future Trend 13.2 Distributors, Traders and Dealers 14 Research Findings and Conclusion 15 Appendix 15.1 Methodology 15.2 Data Source

List of Tables and Figures Figure Orphan Drugs Picture Table Product Specifications of Orphan Drugs Figure Global Sales Market Share of Orphan Drugs by Types in 2017 Table Orphan Drugs Types for Major Manufacturers Figure Oncology Picture Figure Gastrointestinal Picture Figure Pulmonary Picture Figure Neurology Picture Figure Hematology Picture Figure Cardio-vascular Picture Figure Metabolic disorders Picture Figure Endocrinology Picture Figure Infectious diseases Picture Figure Others Picture Figure Orphan Drugs Sales Market Share by Applications in 2017 Figure Hospital Pharmacies Picture Figure Speciality Pharmacies Picture Figure Retail pharmacies Picture Figure Others Picture Figure United States Orphan Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Canada Orphan Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Mexico Orphan Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Germany Orphan Drugs Revenue (Value) and Growth Rate (2013-2023) Figure France Orphan Drugs Revenue (Value) and Growth Rate (2013-2023) Figure UK Orphan Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Russia Orphan Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Italy Orphan Drugs Revenue (Value) and Growth Rate (2013-2023) Figure China Orphan Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Japan Orphan Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Korea Orphan Drugs Revenue (Value) and Growth Rate (2013-2023) Figure India Orphan Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Southeast Asia Orphan Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Brazil Orphan Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Egypt Orphan Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Saudi Arabia Orphan Drugs Revenue (Value) and Growth Rate (2013-2023) Figure South Africa Orphan Drugs Revenue (Value) and Growth Rate (2013-2023) Figure Nigeria Orphan Drugs Revenue (Value) and Growth Rate (2013-2023) Table Novartis Basic Information, Manufacturing Base and Competitors Table Novartis Orphan Drugs Type and Applications Table Novartis Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Bristol-Myers Squibb Basic Information, Manufacturing Base and Competitors Table Bristol-Myers Squibb Orphan Drugs Type and Applications Table Bristol-Myers Squibb Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Celgene Basic Information, Manufacturing Base and Competitors Table Celgene Orphan Drugs Type and Applications Table Celgene Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Roche Basic Information, Manufacturing Base and Competitors Table Roche Orphan Drugs Type and Applications Table Roche Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Pfizer Basic Information, Manufacturing Base and Competitors Table Pfizer Orphan Drugs Type and Applications Table Pfizer Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Sanofi Basic Information, Manufacturing Base and Competitors Table Sanofi Orphan Drugs Type and Applications Table Sanofi Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Alexion Pharmaceuticals Basic Information, Manufacturing Base and Competitors Table Alexion Pharmaceuticals Orphan Drugs Type and Applications Table Alexion Pharmaceuticals Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Eli Lilly Basic Information, Manufacturing Base and Competitors Table Eli Lilly Orphan Drugs Type and Applications Table Eli Lilly Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Novo Nordisk Basic Information, Manufacturing Base and Competitors Table Novo Nordisk Orphan Drugs Type and Applications Table Novo Nordisk Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table AstraZeneca Basic Information, Manufacturing Base and Competitors Table AstraZeneca Orphan Drugs Type and Applications Table AstraZeneca Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Eisai Basic Information, Manufacturing Base and Competitors Table Eisai Orphan Drugs Type and Applications Table Eisai Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Daiichi Sankyo Basic Information, Manufacturing Base and Competitors Table Daiichi Sankyo Orphan Drugs Type and Applications Table Daiichi Sankyo Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Bayer Basic Information, Manufacturing Base and Competitors Table Bayer Orphan Drugs Type and Applications Table Bayer Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table GlaxoSmithKline Basic Information, Manufacturing Base and Competitors Table GlaxoSmithKline Orphan Drugs Type and Applications Table GlaxoSmithKline Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Merck Basic Information, Manufacturing Base and Competitors Table Merck Orphan Drugs Type and Applications Table Merck Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Johnson & Johnson Basic Information, Manufacturing Base and Competitors Table Johnson & Johnson Orphan Drugs Type and Applications Table Johnson & Johnson Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Biogen Basic Information, Manufacturing Base and Competitors Table Biogen Orphan Drugs Type and Applications Table Biogen Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Shire Basic Information, Manufacturing Base and Competitors Table Shire Orphan Drugs Type and Applications Table Shire Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Amgen Basic Information, Manufacturing Base and Competitors Table Amgen Orphan Drugs Type and Applications Table Amgen Orphan Drugs Sales, Price, Revenue, Gross Margin and Market Share (2016-2017) Table Global Orphan Drugs Sales by Manufacturer (2016-2017) Figure Global Orphan Drugs Sales Market Share by Manufacturer in 2016 Figure Global Orphan Drugs Sales Market Share by Manufacturer in 2017 Table Global Orphan Drugs Revenue by Manufacturer (2016-2017) Figure Global Orphan Drugs Revenue Market Share by Manufacturer in 2016 Figure Global Orphan Drugs Revenue Market Share by Manufacturer in 2017 Figure Top 3 Orphan Drugs Manufacturer (Revenue) Market Share in 2017 Figure Top 6 Orphan Drugs Manufacturer (Revenue) Market Share in 2017 Figure Global Orphan Drugs Sales and Growth Rate (2013-2018) Figure Global Orphan Drugs Revenue and Growth Rate (2013-2018) Table Global Orphan Drugs Sales by Regions (2013-2018) Table Global Orphan Drugs Sales Market Share by Regions (2013-2018) Table Global Orphan Drugs Revenue by Regions (2013-2018) Figure Global Orphan Drugs Revenue Market Share by Regions in 2013 Figure Global Orphan Drugs Revenue Market Share by Regions in 2017 Figure North America Orphan Drugs Sales and Growth Rate (2013-2018) Figure Europe Orphan Drugs Sales and Growth Rate (2013-2018) Figure Asia-Pacific Orphan Drugs Sales and Growth Rate (2013-2018) Figure South America Orphan Drugs Sales and Growth Rate (2013-2018) Figure Middle East and Africa Orphan Drugs Sales and Growth Rate (2013-2018) Figure North America Orphan Drugs Revenue and Growth Rate (2013-2018) Table North America Orphan Drugs Sales by Countries (2013-2018) Table North America Orphan Drugs Sales Market Share by Countries (2013-2018) Figure North America Orphan Drugs Sales Market Share by Countries in 2013 Figure North America Orphan Drugs Sales Market Share by Countries in 2017 Table North America Orphan Drugs Revenue by Countries (2013-2018) Table North America Orphan Drugs Revenue Market Share by Countries (2013-2018) Figure North America Orphan Drugs Revenue Market Share by Countries in 2013 Figure North America Orphan Drugs Revenue Market Share by Countries in 2017 Figure United States Orphan Drugs Sales and Growth Rate (2013-2018) Figure Canada Orphan Drugs Sales and Growth Rate (2013-2018) Figure Mexico Orphan Drugs Sales and Growth Rate (2013-2018) Figure Europe Orphan Drugs Revenue and Growth Rate (2013-2018) Table Europe Orphan Drugs Sales by Countries (2013-2018) Table Europe Orphan Drugs Sales Market Share by Countries (2013-2018) Table Europe Orphan Drugs Revenue by Countries (2013-2018) Figure Europe Orphan Drugs Revenue Market Share by Countries in 2016 Figure Europe Orphan Drugs Revenue Market Share by Countries in 2017 Figure Germany Orphan Drugs Sales and Growth Rate (2013-2018) Figure UK Orphan Drugs Sales and Growth Rate (2013-2018) Figure France Orphan Drugs Sales and Growth Rate (2013-2018) Figure Russia Orphan Drugs Sales and Growth Rate (2013-2018) Figure Italy Orphan Drugs Sales and Growth Rate (2013-2018) Figure Asia-Pacific Orphan Drugs Revenue and Growth Rate (2013-2018) Table Asia-Pacific Orphan Drugs Sales by Countries (2013-2018) Table Asia-Pacific Orphan Drugs Sales Market Share by Countries (2013-2018) Figure Asia-Pacific Orphan Drugs Sales Market Share by Countries 2017 Table Asia-Pacific Orphan Drugs Revenue by Countries (2013-2018) Figure Asia-Pacific Orphan Drugs Revenue Market Share by Countries 2017 Figure China Orphan Drugs Sales and Growth Rate (2013-2018) Figure Japan Orphan Drugs Sales and Growth Rate (2013-2018) Figure Korea Orphan Drugs Sales and Growth Rate (2013-2018) Figure India Orphan Drugs Sales and Growth Rate (2013-2018) Figure Southeast Asia Orphan Drugs Sales and Growth Rate (2013-2018) Figure South America Orphan Drugs Revenue and Growth Rate (2013-2018) Table South America Orphan Drugs Sales by Countries (2013-2018) Table South America Orphan Drugs Sales Market Share by Countries (2013-2018) Figure South America Orphan Drugs Sales Market Share by Countries in 2017 Table South America Orphan Drugs Revenue by Countries (2013-2018) Table South America Orphan Drugs Revenue Market Share by Countries (2013-2018) Figure South America Orphan Drugs Revenue Market Share by Countries in 2017 Figure Brazil Orphan Drugs Sales and Growth Rate (2013-2018) Figure Argentina Orphan Drugs Sales and Growth Rate (2013-2018) Figure Colombia Orphan Drugs Sales and Growth Rate (2013-2018) Figure Middle East and Africa Orphan Drugs Revenue and Growth Rate (2013-2018) Table Middle East and Africa Orphan Drugs Sales by Countries (2013-2018) Table Middle East and Africa Orphan Drugs Sales Market Share by Countries (2013-2018) Figure Middle East and Africa Orphan Drugs Sales Market Share by Countries in 2017 Table Middle East and Africa Orphan Drugs Revenue by Countries (2013-2018) Table Middle East and Africa Orphan Drugs Revenue Market Share by Countries (2013-2018) Figure Middle East and Africa Orphan Drugs Revenue Market Share by Countries in 2013 Figure Middle East and Africa Orphan Drugs Revenue Market Share by Countries in 2017 Figure Saudi Arabia Orphan Drugs Sales and Growth Rate (2013-2018) Figure UAE Orphan Drugs Sales and Growth Rate (2013-2018) Figure Egypt Orphan Drugs Sales and Growth Rate (2013-2018) Figure Nigeria Orphan Drugs Sales and Growth Rate (2013-2018) Figure South Africa Orphan Drugs Sales and Growth Rate (2013-2018) Table Global Orphan Drugs Sales by Type (2013-2018) Table Global Orphan Drugs Sales Share by Type (2013-2018) Table Global Orphan Drugs Revenue by Type (2013-2018) Table Global Orphan Drugs Revenue Share by Type (2013-2018) Figure Global Oncology Sales Growth (2013-2018) Figure Global Oncology Price (2013-2018) Figure Global Gastrointestinal Sales Growth (2013-2018) Figure Global Gastrointestinal Price (2013-2018) Figure Global Pulmonary Sales Growth (2013-2018) Figure Global Pulmonary Price (2013-2018) Figure Global Neurology Sales Growth (2013-2018) Figure Global Neurology Price (2013-2018) Figure Global Hematology Sales Growth (2013-2018) Figure Global Hematology Price (2013-2018) Figure Global Cardio-vascular Sales Growth (2013-2018) Figure Global Cardio-vascular Price (2013-2018) Figure Global Metabolic disorders Sales Growth (2013-2018) Figure Global Metabolic disorders Price (2013-2018) Figure Global Endocrinology Sales Growth (2013-2018) Figure Global Endocrinology Price (2013-2018) Figure Global Infectious diseases Sales Growth (2013-2018) Figure Global Infectious diseases Price (2013-2018) Figure Global Others Sales Growth (2013-2018) Figure Global Others Price (2013-2018) Table Global Orphan Drugs Sales by Application (2013-2018) Table Global Orphan Drugs Sales Share by Application (2013-2018) Figure Global Speciality Pharmacies Sales Growth (2013-2018) Figure Global Retail pharmacies Sales Growth (2013-2018) Figure Global Others Sales Growth (2013-2018) Figure Global Orphan Drugs Sales, Revenue and Growth Rate (2018-2023) Table Global Orphan Drugs Sales Forecast by Regions (2018-2023) Table Global Orphan Drugs Market Share Forecast by Regions (2018-2023) Figure North America Sales Orphan Drugs Market Forecast (2018-2023) Figure Europe Sales Orphan Drugs Market Forecast (2018-2023) Figure Asia-Pacific Sales Orphan Drugs Market Forecast (2018-2023) Figure South America Sales Orphan Drugs Market Forecast (2018-2023) Figure Middle East and Africa Sales Orphan Drugs Market Forecast (2018-2023) Table Global Orphan Drugs Sales Forecast by Type (2018-2023) Table Global Orphan Drugs Market Share Forecast by Type (2018-2023) Table Global Orphan Drugs Sales Forecast by Application (2018-2023) Table Global Orphan Drugs Market Share Forecast by Application (2018-2023) Table Distributors/Traders/ Dealers List

Novartis Bristol-Myers Squibb Celgene Roche Pfizer Sanofi Alexion Pharmaceuticals Eli Lilly Novo Nordisk AstraZeneca Eisai Daiichi Sankyo Bayer GlaxoSmithKline Merck Johnson & Johnson Biogen Shire Amgen